$44.370
-0.328 (-0.74%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
COAG-Prognose durch Analyse ähnlicher Charts
Alphio's COAG stock price prediction model matches the current Hemab Therapeutics Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $45.19 (+1.85%). The 1-week path is $46.13 (+3.96%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Hemab Therapeutics Holdings Inc-Aktien kaufen?
Currently, Hemab Therapeutics (COAG) is trading at $44.84, significantly below the average analyst price target of $60, indicating potential upside. However, the stock has a low RSI of 29.128, suggesting it is oversold, but it also reported a wider Q2 loss of $24.2 million, which raises concerns about its financial health. Therefore, while there is potential for recovery, the current financial losses and market volatility suggest a cautious approach.
COAG schloss am Thursday bei $44.37, nachdem der Kurs -0.74% fallen
Hemab Therapeutics Holdings Inc (COAG) last closed at $44.37, losing -0.74%. These facts feed the 1-day and 1-week COAG price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Hemab Therapeutics Holdings Inc (COAG) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf COAG am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für COAG
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.